An Epidemiological Surveillance Study to Evaluate the Incidence of Dengue in Brazil
Dengue
About this trial
This is an interventional other trial for Dengue focused on measuring Endemic regions, Brazil, Incidence, Surveillance, Dengue
Eligibility Criteria
Inclusion Criteria:
- Written, signed or thumb-printed informed consent (and assent when applicable) must be obtained from the subject or subject's parent(s)/legally acceptable representative(s) (LAR(s)). If the subject/subject's parent(s)/LAR(s) are illiterate the consent form will be countersigned by a witness.
- Male or female at least 6 months of age at the time of enrollment.
- Subject and/or subject's parent(s)/LAR(s) who the study staff believes can comply with the requirements of the protocol.
- Subject who plans, at the time of enrollment, to remain at same residence/study area during their study participation period).
Exclusion Criteria:
- Child in care.
- Participation (current or planned) in another epidemiological study or in a clinical trial that would conflict with the current study, based on investigator's judgement.
- Terminal illness or severe mental incapacity.
Sites / Locations
- GSK Investigational Site
- GSK Investigational Site
- GSK Investigational Site
- GSK Investigational Site
- GSK Investigational Site
Arms of the Study
Arm 1
Other
Total Group
Subjects six months of age and older at the time of enrolment, recruited from randomly selected households originating from preselected mapped communities. Preferably the recruitment period occurred outside of the peak dengue transmission season, and continued until each site had reached its foreseen target. The expected period for recruiting the target sample size was approximately three months. Recruitment of replacement subjects was done during the low dengue transmission and the recruitment period depended on the number of subjects that need to be replaced. Enrolled subjects were subjects who either lived in households in study areas with support from the Family Health Physician Program (FHP) or the Larval Index Rapid Assay (LIRA) or with field research experience in the community (preferred) or where a similar system of mapped communities with potential for surveillance existed.